After GetSwift, judge could not hear split trial in Revlimid patent case, court told
Intellectual Property 2021-07-20 8:39 pm By Christine Caulfield | Melbourne

Save(0) Please login to bookmark Username or Email Address Password Remember Me A proposal by Bristol-Myers Squibb-owned Celgene to split a second trial into two […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.